Taro Provides Results for December 31, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
Taro Pharma (TARO) Reports Q3 EPS of $1.37
February 7, 2018 5:28 PM ESTTaro Pharma (NYSE: TARO) reported Q3 EPS of $1.37, versus $3.42 reported last year. Revenue for the quarter came in at $155.5 million, versus $220.4 million reported last year.
Net income attributable to Taro was $18.0 million compared to $139.8 million, resulting in diluted earnings per share of $0.45... More



